Galectin-3: can it be a diagnostic tool for pneumonia in covid-19 patients?

Background/aim: Biochemical markers are needed to show lung involvement in COVID-19 disease. Galectin-3 is known to play a key role in the inflammation and fibrosis process. We aimed to evaluate the predictive role of galectin-3 levels for pneumonia in patients with COVID-19. Materials and methods: Total of 176 patients with COVID-19, confirmed with reverse transcriptase polymerase chain reaction, admitted to the Erzurum Regional Training and Research Hospital was analyzed. The study was designed as a cross sectional. The baseline data of laboratory examinations, including galectin-3 were collected at the time of diagnosis. CT images evaluated by a single radiologist according to the recommendation of the Radiological Society of North America Expert Consensus Document for pulmonary involvement. The severity of COVID-19 pneumonia was assessed using the total severity score. Results: The mean galectin-3 level in patients with typical pneumonia was found to be significantly higher than those patients with atypical (p < 0.01) and indeterminate appearance (p < 0.01) and patients without pneumonia (p < 0.01). The severity of lung involvement was significantly associated with Galectin-3 levels (p < 0.01 r: 0.76). Stepwise logistic regression model showed that the levels of ferritin (odds ratio [OR] = 0.05, p: 0.08) and galectin-3 (OR = 0.1, p < 0.01) were significantly and independently associated with typical pneumoniain COVID-19 patients. When COVID-19 patients were evaluated in terms of typical pneumonia, we determined a cut-off value of 18.9 ng/mL for galectin-3 via ROC analysis (87% sensitivity; 73% specificity; area under curve (AUC): 0.89; p < 0.001). Conclusion: Galectin-3 was found as a diagnostic tool for COVID-19 associated typical pneumonia and as an indicator of both pneumonia and its severity.Key words: Galectin-3, covid-19, pneumonia

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Shi Y, Wang G, Cai XP, Deng JW, Zheng L et al. An overview of COVID-19. Journal of Zhejiang University Science B (Biomedicine & Biotechnology) 2020; 21 (5): 343-360. doi: 10.1631/jzus.B2000083
2. Zu ZY, Jiang MD, Xu PP, Chen W, Ni QQ et al. Coronavirus disease 2019 (COVID-19). A Perspective From China Radiology 2020; 296 (2): E15-E25. doi: 10.1148/radiol.2020200490
3. Chams N, Chams S, Badran R, Shams A, Araji A et al. COVID-19: a multidisciplinary review. Front Public Health 2020; 29 (8): 383. doi: 10.3389/fpubh.2020.00383
4. Rodrigues JCL, Hare SS, Edey A, Devaraj A, Jacob J et al. An update on COVID-19 for the radiologist - A British Society of Thoracic Imaging Statement. Clinical Radiology 2020; 75 (5): 323-325. doi: 10.1016/j.crad.2020.03.003
5. Harapan H, Itoh N, Yufika A, Winardi W, Keam S et al. Coronavirus disease 2019 (COVID-19): a literature review. Journal of Infection and Public Health 2020; 13 (5): 667-673. doi: 10.1016/j.jiph.2020.03.019
6. Caniglia JL, Asuthkar S, Tsung AJ, Guda MR, Velpula KK. Immunopathology of galectin-3: an increasingly promising target in COVID-19. F1000 Research 2020; 1 (9): 1078. doi: 10.12688/f1000research.25979.2
7. MacKinnon AC, Farnworth SL, Hodkinson PS, Henderson NC, Atkinson KM et al. Regulation of alternative macrophage activation by galectin-3. Journal of Immunology 2008; 180 (4): 2650-2658. doi: 10.4049/jimmunol.180.4.2650
8. Xu Z, Li X, Huang Y, Mao P, Wu S et al. The Predictive value of plasma galectin-3 for ards severity and clinical outcome. Shock 2017; 47 (3): 331-336. doi: 10.1097/SHK.0000000000000757.9
9. De Biasi S, Meschiari M, Gibellini L, Bellinazzi C, Borella R et al. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nature Communications 2020; 11 (1): 3434. doi: 10.1038/s41467-020- 17292-4
10. Kalfaoglu B, Almeida-Santos J, Tye CA, Satou Y, Ono M. T-cell hyperactivation and paralysis in severe COVID-19 infection revealed by single-cell analysis. Frontiers in Immunology 2020; 8 (11): 589380. doi: 10.3389/fimmu.2020.589380
11. Liu X, Zhu A, He J, Chen Z, Liu L et al. Single-cell analysis reveals macrophage-driven T cell dysfunction in severe COVID-19 patients. Protein Cell 2020; 11: 680-687. doi: 10.1007/s13238-020- 00752-4
12. Henderson NC, Mackinnon AC, Farnworth SL, Kipari T, Haslett C et al. Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis. The American Journal of Pathology 2008; 172 (2): 288-298. doi: 10.2353/ajpath.2008.070726
13. Yu L, Ruifrok WPT, Meissner M, Bos EM, Van Goor H et al. Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis. Circulation Heart Failure 2013; 6 (1): 107-117. doi: 10.1161/circheartfailure.112.971168
14. Luo H, Liu B, Zhao L, He J, Li T et al. Galectin-3 mediates pulmonary vascular remodeling in hypoxia-induced pulmonary arterial hypertension. Journal of The American Society of Hypertension 2017; 11 (10): 673-683. doi: 10.1016/j.jash.2017.07.009
15. Spagnolo P, Balestro E, Aliberti S, Cocconcelli E, Biondini D et al. Pulmonary fibrosis secondary to COVID-19: a call to arms? The Lancet Respiratory Medicine 2020; 8 (8): 750-752. doi: 10.1016/S2213-2600(20)30222-8
16. Simpson S, Kay FU, Abbara S, Bhalla S, Chung JH et al. Radiological Society of North America expert consensus document on reporting chest CT findings related to COVID-19: endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA. Journal of Thoracic Imaging 2020; 35 (4): 219-227. doi: 10.1148/ryct.2020200152
17. Li K, Fang Y, Li W, Pan C, Qin P et al. CT image visual quantitative evaluation and clinical classification of coronavirus disease (COVID-19). European Radiology 2020; 30 (8): 4407-4416. doi: 10.1007/s00330-020-06817-6 18. Garcia-Revilla J, Deierborg T, Venero JL, Boza-Serrano A. Hyperinflammation and fibrosis in severe COVID-19 patients: galectin-3, a target molecule to consider. Front Immunology 2020;
18 (11): 2069. doi: 10.3389/fimmu.2020.02069
19. Ho JE, Gao W, Levy D, Santhanakrishnan R, Araki T et al. Galectin-3 is associated with restrictive lung disease and interstitial lung abnormalities. American Journal of Respiratory and Critical Care Medicine 2016; 194 (1): 77-83. doi: 10.1164/rccm.201509- 1753OC
20. Islam N, Salameh J-P, Leeflang MM, Hooft L, McGrath TA et al. Thoracic imaging tests for the diagnosis of COVID-19. The Cochrane Database of Systematic Reviews 2020; 26 (11): CD013639. doi: 10.1002/14651858.CD013639.pub3
21. Ai T, Yang Z, Hou H, Zhan C, Chen C et al. Correlation of chest CT and RT-PCR testing for coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology 2020; 296 (2): 32-40. doi: 10.1148/radiol.2020200642
22. Hu Z, Song C, Xu C, Jin G, Chen Y et al. Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. Science China Life Sciences 2020; 63 (5): 706-711. doi: 10.1007/s11427-020-1661-4
23. Inui S, Fujikawa A, Jitsu M, Kunishima N, Watanabe S et al. Chest CT findings in cases from the cruise ship diamond princess with coronavirus disease (COVID-19) . Radiology Cardiothorac Imaging 2020; 2 (2): e200110. doi: 10.1148/ryct.2020200110
24. Dennie C, Hague C, Lim RS, Manos D, Memauri BF et al. Canadian Society of Thoracic Radiology/Canadian Association of Radiologists consensus statement regarding chest imaging in suspected and confirmed COVID-19. Canadian Association of Radiologists Journal 2020; 71 (4): 470-481. doi: 10.1177/0846537120924606
25. Fang Y, Zhang H, Xie J, Lin M, Ying L et al. Sensitivity of Chest CT for COVID-19: comparison to RT-PCR. Radiology 2020; 296 (2): E115-E117. doi: 10.1148/radiol.2020200432
26. Wasilewski PG, Mruk B, Mazur S, Półtorak-Szymczak G, Sklinda K et al. COVID-19 severity scoring systems in radiological imaging - a review. Polish Journal of Radiology 2020; 17 (85): e361-e368. doi: 10.5114/pjr.2020.98009
27. Yang Y, Zhu J-F, Yang S-Y, Lin H-J, Chen Y et al. Prevalence and associated factors of poor sleep quality among Chinese returning workers during the COVID-19 pandemic. Sleep Medicine 2020; 1 (73): 47-52. doi: 10.1016/j.sleep.2020.06.034
28. Liu N, Zhang F, Wei C, Jia Y, Shang Z et al. Prevalence and predictors of PTSS during COVID-19 outbreak in China hardesthit areas: gender differences matter. Psychiatry Research 2020; 287: 112921. doi: 10.1016/j.psychres.2020.112921
29. Herold T, Jurinovic V, Arnreich C, Lipworth BJ, Hellmuth JC et al. Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19. The Journal of Allergy and Clinical Immunology 2020; 146 (1): 128-136. doi: 10.1016/j.jaci.2020.05.008
30. Poggiali E, Zaino D, Immovilli P, Rovero L, Losi G et al. Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients. International Journal of Clinical Chemistry 2020; 1 (509): 135-138. doi: 10.1016/j.cca.2020.06.012
31. Tan C, Huang Y, Shi F, Tan K, Ma Q et al. C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early. Journal of Medical Virology 2020; 92 (7): 856-862. doi: 10.1002/jmv.25871
32. Ponti G, Maccaferri M, Ruini C, Tomasi A, Ozben T. Biomarkers associated with COVID-19 disease progression. Critical Reviews in Clinical Laboratory Sciences 2020; 57 (6): 389-399. doi: 10.1080/10408363.2020.1770685
33. An PJ, Zhu YZ, Yang LP. Biochemical indicators of coronavirus disease 2019 exacerbation and the clinical implications. Pharmacological Research 2020; 159: 104946. doi: 10.1016/j.phrs.2020.104946

APA	BAYKAN E, şebin e, Karaşahin Ö, Baykan A, CERRAH S, GÖĞEBAKAN H, Sevinc C, kahraman M, COŞKUN YAVUZ Y (2021). Galectin-3: can it be a diagnostic tool for pneumonia in covid-19 patients?. , 2256 - 2262. 10.3906/sag-2102-202
Chicago	BAYKAN Emine KARTAL,şebin engin,Karaşahin Ömer,Baykan Ahmed Ramiz,CERRAH Serkan,GÖĞEBAKAN Hasan,Sevinc Can,kahraman MUSTAFA,COŞKUN YAVUZ Yasemin Galectin-3: can it be a diagnostic tool for pneumonia in covid-19 patients?. (2021): 2256 - 2262. 10.3906/sag-2102-202
MLA	BAYKAN Emine KARTAL,şebin engin,Karaşahin Ömer,Baykan Ahmed Ramiz,CERRAH Serkan,GÖĞEBAKAN Hasan,Sevinc Can,kahraman MUSTAFA,COŞKUN YAVUZ Yasemin Galectin-3: can it be a diagnostic tool for pneumonia in covid-19 patients?. , 2021, ss.2256 - 2262. 10.3906/sag-2102-202
AMA	BAYKAN E,şebin e,Karaşahin Ö,Baykan A,CERRAH S,GÖĞEBAKAN H,Sevinc C,kahraman M,COŞKUN YAVUZ Y Galectin-3: can it be a diagnostic tool for pneumonia in covid-19 patients?. . 2021; 2256 - 2262. 10.3906/sag-2102-202
Vancouver	BAYKAN E,şebin e,Karaşahin Ö,Baykan A,CERRAH S,GÖĞEBAKAN H,Sevinc C,kahraman M,COŞKUN YAVUZ Y Galectin-3: can it be a diagnostic tool for pneumonia in covid-19 patients?. . 2021; 2256 - 2262. 10.3906/sag-2102-202
IEEE	BAYKAN E,şebin e,Karaşahin Ö,Baykan A,CERRAH S,GÖĞEBAKAN H,Sevinc C,kahraman M,COŞKUN YAVUZ Y "Galectin-3: can it be a diagnostic tool for pneumonia in covid-19 patients?." , ss.2256 - 2262, 2021. 10.3906/sag-2102-202
ISNAD	BAYKAN, Emine KARTAL vd. "Galectin-3: can it be a diagnostic tool for pneumonia in covid-19 patients?". (2021), 2256-2262. https://doi.org/10.3906/sag-2102-202

APA	BAYKAN E, şebin e, Karaşahin Ö, Baykan A, CERRAH S, GÖĞEBAKAN H, Sevinc C, kahraman M, COŞKUN YAVUZ Y (2021). Galectin-3: can it be a diagnostic tool for pneumonia in covid-19 patients?. Turkish Journal of Medical Sciences, 51(5), 2256 - 2262. 10.3906/sag-2102-202
Chicago	BAYKAN Emine KARTAL,şebin engin,Karaşahin Ömer,Baykan Ahmed Ramiz,CERRAH Serkan,GÖĞEBAKAN Hasan,Sevinc Can,kahraman MUSTAFA,COŞKUN YAVUZ Yasemin Galectin-3: can it be a diagnostic tool for pneumonia in covid-19 patients?. Turkish Journal of Medical Sciences 51, no.5 (2021): 2256 - 2262. 10.3906/sag-2102-202
MLA	BAYKAN Emine KARTAL,şebin engin,Karaşahin Ömer,Baykan Ahmed Ramiz,CERRAH Serkan,GÖĞEBAKAN Hasan,Sevinc Can,kahraman MUSTAFA,COŞKUN YAVUZ Yasemin Galectin-3: can it be a diagnostic tool for pneumonia in covid-19 patients?. Turkish Journal of Medical Sciences, vol.51, no.5, 2021, ss.2256 - 2262. 10.3906/sag-2102-202
AMA	BAYKAN E,şebin e,Karaşahin Ö,Baykan A,CERRAH S,GÖĞEBAKAN H,Sevinc C,kahraman M,COŞKUN YAVUZ Y Galectin-3: can it be a diagnostic tool for pneumonia in covid-19 patients?. Turkish Journal of Medical Sciences. 2021; 51(5): 2256 - 2262. 10.3906/sag-2102-202
Vancouver	BAYKAN E,şebin e,Karaşahin Ö,Baykan A,CERRAH S,GÖĞEBAKAN H,Sevinc C,kahraman M,COŞKUN YAVUZ Y Galectin-3: can it be a diagnostic tool for pneumonia in covid-19 patients?. Turkish Journal of Medical Sciences. 2021; 51(5): 2256 - 2262. 10.3906/sag-2102-202
IEEE	BAYKAN E,şebin e,Karaşahin Ö,Baykan A,CERRAH S,GÖĞEBAKAN H,Sevinc C,kahraman M,COŞKUN YAVUZ Y "Galectin-3: can it be a diagnostic tool for pneumonia in covid-19 patients?." Turkish Journal of Medical Sciences, 51, ss.2256 - 2262, 2021. 10.3906/sag-2102-202
ISNAD	BAYKAN, Emine KARTAL vd. "Galectin-3: can it be a diagnostic tool for pneumonia in covid-19 patients?". Turkish Journal of Medical Sciences 51/5 (2021), 2256-2262. https://doi.org/10.3906/sag-2102-202